# SERINC4

## Overview
SERINC4, or serine incorporator 4, is a gene that encodes a type III integral membrane protein involved in the incorporation of serine into membrane lipids, a process crucial for lipid biosynthesis and maintaining membrane integrity. The SERINC4 protein is characterized by multiple transmembrane domains and is part of the SERINC family, which plays roles in membrane trafficking and signal transduction, impacting cellular growth and communication (Azizi2022Whole; Qiu2020Proteasomal). Notably, SERINC4 has been implicated in antiviral defense mechanisms, particularly in inhibiting HIV-1 infectivity. This is achieved through its incorporation into HIV-1 virions, which enhances the virus's sensitivity to neutralizing antibodies and restricts viral replication. The protein's antiviral activity is modulated by its N-terminal region, which is essential for its function and expression, and is subject to post-translational modifications such as glycosylation (Qiu2020Proteasomal).

## Structure
The SERINC4 protein is a member of the SERINC family, which are type III integral membrane proteins. It is predicted to have multiple transmembrane domains, although it may lack a second transmembrane domain, which could lead to a unique glycosylation profile and protein structure compared to other SERINC proteins (Qiu2020Proteasomal). The predicted molecular weight of SERINC4 is approximately 57 kDa, but it is often detected as a monomeric form at 45 kDa and as high-molecular-weight species ranging from 50 to 100 kDa. These high-molecular-weight forms may result from protein aggregation or post-translational modifications such as N-glycosylation, which is known to affect SERINC5 (Qiu2020Proteasomal).

The N-terminal region of SERINC4, particularly the first 34 amino acids, is crucial for its antiviral activity, while the region from amino acids 35 to 92 influences its expression (Qiu2020Proteasomal). The variability in the N-terminal regions across species has been studied, with chimeric proteins created to identify specific amino acid regions that determine antiviral activity and protein expression (Qiu2020Proteasomal). The molecular structure of SERINC4 is not directly detailed in the available sources, but its role in HIV-1 restriction and interaction with viral proteins like Nef has been a focus of research.

## Function
SERINC4 (serine incorporator 4) is a protein involved in the incorporation of serine into membrane lipids, which is essential for lipid biosynthesis and maintaining membrane integrity. This protein is active in the cell membrane and plays a role in cellular processes such as membrane trafficking and signal transduction, impacting cell growth and communication (Azizi2022Whole).

In the context of its antiviral activity, SERINC4 is known for its role in inhibiting HIV-1 infectivity. Despite being expressed at significantly lower levels than its paralog SERINC5 due to proteasomal degradation, SERINC4 can restrict HIV-1 replication effectively when its expression is normalized. This antiviral mechanism involves the incorporation of SERINC4 into HIV-1 virions, which increases the virus's sensitivity to neutralizing antibodies and restricts viral replication (Qiu2020Proteasomal).

SERINC4's antiviral activity is modulated by its N-terminal region, which is crucial for its function and expression. The protein undergoes post-translational modifications, such as glycosylation, which may affect its stability and function. The HIV-1 Nef protein can antagonize SERINC4 by targeting it for lysosomal degradation, suggesting a mechanism by which HIV-1 evades the host's antiviral defenses (Qiu2020Proteasomal).

## Interactions
SERINC4 interacts with the HIV-1 Nef protein, which antagonizes its antiviral activity by promoting its degradation through the lysosomal pathway. This interaction is significant because it reduces the expression of SERINC4, thereby diminishing its ability to inhibit HIV-1 replication (Qiu2020Proteasomal). Despite its low expression levels due to proteasomal degradation, SERINC4 can still be incorporated into HIV-1 virions, where it increases the virus's sensitivity to broadly neutralizing antibodies (Qiu2020Proteasomal).

The N-terminal region of SERINC4 is crucial for its antiviral activity and expression. Modifications to this region can stabilize SERINC4 and enhance its antiviral effects, suggesting that specific amino acids in this region are important for its interactions and function (Qiu2020Proteasomal). The study of chimeric proteins, where regions of SERINC4 are swapped with those from other SERINC proteins, has shown that these modifications can lead to increased expression and antiviral activity, highlighting the importance of the N-terminal region in mediating interactions that affect SERINC4's function (Qiu2020Proteasomal).


## References


[1. (Azizi2022Whole) Hossein Azizi, Danial Hashemi Karoii, and Thomas Skutella. Whole exome sequencing and in silico analysis of human sertoli in patients with non-obstructive azoospermia. International Journal of Molecular Sciences, 23(20):12570, October 2022. URL: http://dx.doi.org/10.3390/ijms232012570, doi:10.3390/ijms232012570. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232012570)

[2. (Qiu2020Proteasomal) Xusheng Qiu, Ifeanyichukwu E. Eke, Silas F. Johnson, Chan Ding, and Yong-Hui Zheng. Proteasomal degradation of human serinc4: a potent host anti-hiv-1 factor that is antagonized by nef. Current Research in Virological Science, 1:100002, 2020. URL: http://dx.doi.org/10.1016/j.crviro.2020.100002, doi:10.1016/j.crviro.2020.100002. This article has 8 citations.](https://doi.org/10.1016/j.crviro.2020.100002)